Back to Journals » Drug, Healthcare and Patient Safety » Volume 7

Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States

Total article views   Abstract views HTML views PDF downloads Totals
10,544 Dovepress* 9,101 758+ 658 9,859
PubMed Central* 0 685 203 685
Totals 9,101 1,443 861 10,544
*Since 15 December 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
18 0 0 0 8 10

View citations on PubMed Central and Google Scholar